Kimura, S.; Iwano, S.; Akioka, T.; Kuchimaru, T.; Kawaguchi, M.; Fukushima, T.; Sato, Y.; Kataoka, H.; Kamoto, T.; Mukai, S.;
et al. Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC. Int. J. Mol. Sci. 2025, 26, 2308.
https://doi.org/10.3390/ijms26052308
AMA Style
Kimura S, Iwano S, Akioka T, Kuchimaru T, Kawaguchi M, Fukushima T, Sato Y, Kataoka H, Kamoto T, Mukai S,
et al. Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC. International Journal of Molecular Sciences. 2025; 26(5):2308.
https://doi.org/10.3390/ijms26052308
Chicago/Turabian Style
Kimura, Shoichi, Satoshi Iwano, Takahiro Akioka, Takahiro Kuchimaru, Makiko Kawaguchi, Tsuyoshi Fukushima, Yuichiro Sato, Hiroaki Kataoka, Toshiyuki Kamoto, Shoichiro Mukai,
and et al. 2025. "Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC" International Journal of Molecular Sciences 26, no. 5: 2308.
https://doi.org/10.3390/ijms26052308
APA Style
Kimura, S., Iwano, S., Akioka, T., Kuchimaru, T., Kawaguchi, M., Fukushima, T., Sato, Y., Kataoka, H., Kamoto, T., Mukai, S., & Sawada, A.
(2025). Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC. International Journal of Molecular Sciences, 26(5), 2308.
https://doi.org/10.3390/ijms26052308
